Quarterly report pursuant to Section 13 or 15(d)

Consolidated Balance Sheets

v3.20.2
Consolidated Balance Sheets - USD ($)
$ in Thousands
Sep. 30, 2020
Dec. 31, 2019
Current assets:    
Cash and cash equivalents $ 24,608 $ 17,740
Inventory 1,784  
Prepaid expenses and other current assets 2,563 2,395
Total current assets 28,955 20,135
Property, plant and equipment, net 4,835 4,821
Intangible assets, net 24,898 26,400
Goodwill 2,127 2,127
Other long-term assets 652 730
Total assets 61,467 54,213
Current liabilities:    
Accounts payable 1,782 271
Accrued expenses and other current liabilities 7,292 3,850
Current portion of long-term debt, net 171  
Current portion of contingent consideration 10,677 3,592
Total current liabilities 19,922 7,713
Long-term debt, net 8,753  
Warrant liability 10,228  
Long-term portion of contingent consideration 67,433 62,766
Other long-term liabilities 361 455
Total liabilities 106,697 70,934
Commitments and contingencies (Note 12)
Shareholders’ equity:    
Preferred stock, $0.01 par value. Authorized, 10,000,000 shares; none issued and outstanding
Common stock, $0.01 par value. Authorized, 100,000,000 shares; issued and outstanding, 18,374,604 shares at September 30, 2020 and 9,350,709 shares at December 31, 2019 184 94
Additional paid-in capital 49,864 19,405
Accumulated deficit (95,278) (36,220)
Total shareholders’ equity (deficit) (45,230) (16,721)
Total liabilities and shareholders’ equity $ 61,467 $ 54,213